Review
doi: 10.1111/apt.12682. Epub 2014 Mar 4. Systematic review with meta-analysis: the incidence of advanced neoplasia after polypectomy in patients with and without low-risk adenomasAffiliations
AffiliationItem in Clipboard
Review
Systematic review with meta-analysis: the incidence of advanced neoplasia after polypectomy in patients with and without low-risk adenomasC Hassan et al. Aliment Pharmacol Ther. 2014 May.
doi: 10.1111/apt.12682. Epub 2014 Mar 4. AffiliationItem in Clipboard
AbstractBackground: Patients with one to two tubular adenomas <1 cm in size without high-grade dysplasia (low-risk group) are considered at low risk for colorectal cancer. However, it is uncertain whether they have the same risk of subsequent advanced neoplasia as those with no neoplasia at baseline colonoscopy.
Aim: To compare incidence of metachronous advanced neoplasia between patients in the low-risk adenoma group and those without neoplasia at index colonoscopy.
Methods: Relevant publications were identified by MEDLINE/EMBASE and other databases for the period 1992-2013. Studies comparing the incidence of post-polypectomy advanced neoplasia (adenomas ≥10 mm/high-grade dysplasia/villous or cancer) between the low-risk group and patients without colorectal neoplasia at the first colonoscopy were included. Detection rates for advanced neoplasia at endoscopic surveillance were extracted. Study quality was ascertained according to Newcastle-Ottawa Scale. Forest plot was produced based on random-effect models. Inter-study heterogeneity was assessed using the I(2) statistic.
Results: Seven studies provided data on 11 387 patients. Mean surveillance periods ranged between 2 and 5 years. Altogether, 267 patients with post-polypectomy advanced neoplasia were detected in the two groups. The incidence of advanced neoplasia was 1.6% (119/7308) in those without neoplasia and 3.6% (148/4079) in those with low-risk adenoma, respectively, corresponding to a relative risk of 1.8 (95% CI: 1.3-2.6). Inter-study heterogeneity was only moderate (I(2) : 37%). No publication bias was present.
Conclusions: Patients with low-risk adenomas at baseline had a higher risk of metachronous advanced neoplasia than the group with no adenomas at baseline, though the absolute risk was low in both groups.
© 2014 John Wiley & Sons Ltd.
Similar articlesLieberman D, Sullivan BA, Hauser ER, Qin X, Musselwhite LW, O'Leary MC, Redding TS 4th, Madison AN, Bullard AJ, Thomas R, Sims KJ, Williams CD, Hyslop T, Weiss D, Gupta S, Gellad ZF, Robertson DJ, Provenzale D. Lieberman D, et al. Gastroenterology. 2020 Mar;158(4):862-874.e8. doi: 10.1053/j.gastro.2019.07.052. Epub 2019 Jul 31. Gastroenterology. 2020. PMID: 31376388
Hartstein JD, Vemulapalli KC, Rex DK. Hartstein JD, et al. Gastrointest Endosc. 2020 Mar;91(3):614-621.e6. doi: 10.1016/j.gie.2019.08.047. Epub 2019 Sep 13. Gastrointest Endosc. 2020. PMID: 31525360
Martínez ME, Baron JA, Lieberman DA, Schatzkin A, Lanza E, Winawer SJ, Zauber AG, Jiang R, Ahnen DJ, Bond JH, Church TR, Robertson DJ, Smith-Warner SA, Jacobs ET, Alberts DS, Greenberg ER. Martínez ME, et al. Gastroenterology. 2009 Mar;136(3):832-41. doi: 10.1053/j.gastro.2008.12.007. Epub 2008 Dec 9. Gastroenterology. 2009. PMID: 19171141 Free PMC article.
Kim SY, Kwak MS, Yoon SM, Jung Y, Kim JW, Boo SJ, Oh EH, Jeon SR, Nam SJ, Park SY, Park SK, Chun J, Baek DH, Choi MY, Park S, Byeon JS, Kim HK, Cho JY, Lee MS, Lee OY; Korean Society of Gastrointestinal Endoscopy; Korean Society of Gastroenterology; Korean Association for the Study of Intestinal Diseases. Kim SY, et al. Korean J Gastroenterol. 2022 Sep 25;80(3):115-134. doi: 10.4166/kjg.2022.103. Korean J Gastroenterol. 2022. PMID: 36156035 Review. Korean.
Baile-Maxía S, Mangas-Sanjuán C, Ladabaum U, Sánchez-Ardila C, Sala-Miquel N, Hassan C, Rutter MD, Bretthauer M, Zapater P, Jover R. Baile-Maxía S, et al. Gastrointest Endosc. 2024 Oct;100(4):605-615.e14. doi: 10.1016/j.gie.2024.05.021. Epub 2024 Jun 6. Gastrointest Endosc. 2024. PMID: 38851458 Review.
Trivedi M, Mai D, Gupta S. Trivedi M, et al. Gastro Hep Adv. 2022 Nov 29;2(3):298-300. doi: 10.1016/j.gastha.2022.11.011. eCollection 2023. Gastro Hep Adv. 2022. PMID: 39132662 Free PMC article. Review. No abstract available.
Kim SY, Kwak MS, Yoon SM, Jung Y, Kim JW, Boo SJ, Oh EH, Jeon SR, Nam SJ, Park SY, Park SK, Chun J, Baek DH, Choi MY, Park S, Byeon JS, Kim HK, Cho JY, Lee MS, Lee OY; Korean Society of Gastrointestinal Endoscopy; Korean Society of Gastroenterology; Korean Association for the Study of Intestinal Diseases. Kim SY, et al. Intest Res. 2023 Jan;21(1):20-42. doi: 10.5217/ir.2022.00096. Epub 2023 Jan 31. Intest Res. 2023. PMID: 36751043 Free PMC article. Review.
Shaw E, Farris MS, Stone CR, Derksen JWG, Johnson R, Hilsden RJ, Friedenreich CM, Brenner DR. Shaw E, et al. BMC Cancer. 2018 Jan 11;18(1):71. doi: 10.1186/s12885-017-3970-5. BMC Cancer. 2018. PMID: 29325535 Free PMC article. Review.
Clavenna MG, La Vecchia M, Sculco M, Joseph S, Barberis E, Amede E, Mellai M, Brossa S, Borgonovi G, Occhipinti P, Boldorini R, Robotti E, Azzimonti B, Bona E, Pasolli E, Ferrante D, Manfredi M, Aspesi A, Dianzani I. Clavenna MG, et al. Cancers (Basel). 2023 Jun 6;15(12):3065. doi: 10.3390/cancers15123065. Cancers (Basel). 2023. PMID: 37370676 Free PMC article.
Anderson JC, Rex DK, Robinson C, Butterly LF. Anderson JC, et al. Gastrointest Endosc. 2019 Sep;90(3):495-501. doi: 10.1016/j.gie.2019.05.029. Epub 2019 May 22. Gastrointest Endosc. 2019. PMID: 31125546 Free PMC article.
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.3